Please assess the completion status of the following clinical trial:

Trial Title: Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* chest discomfort lasting at least 15 min within the last 24 h,~* new \>l mm ST-wave or dynamic T-wave changes in at least two contiguous ECG leads,~* troponin I levels above the 99th percentile 6-12 h after the onset of chest pain~* patients referred to the cardiac catheterization laboratory within 24 h of symptoms.~Exclusion Criteria:~* left ventricular ejection fraction less than 25%,~* hemorrhagic diatheses,~* contraindications or allergy to aspirin, thienopyridines, and history of anaphylaxis in response to iodinated contrast medium,~* serum creatinine level of more than 2.0 mg/dl (177 μmol/l),~* leukocyte count of less than 3500/mm3, platelet count of less than 100,000/mm3~* coexisting conditions that limited life expectancy to less than 24 months or that could affect a patient's compliance with the protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- control (Type: NO_INTERVENTION): No hyperglycemia patient group
- Insulin 1 (Type: ACTIVE_COMPARATOR): Conventional insulin treatment
- Insulin (Type: EXPERIMENTAL): Intensive insulin treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).